Navigation Links
University of Chicago and Ataxia Foundation team up for annual scientific and patient meetings
Date:3/5/2010

The National Ataxia Foundation (NAF), in conjunction with the University of Chicago program in pathobiology and translational neuroscience, will hold its third annual Ataxia Investigators Meeting March 9-11, 2010, at the Hyatt Regency O'Hare, in Rosemont, Ill. A three-day meeting for patients, caregivers and families will follow at the same location.

A rare and poorly understood group of degenerative neurological disorders for which there is no effective treatment, ataxia affects an estimated 150,000 people in the United States. A disease of the cerebellum, ataxia robs it victims of their ability to coordinate movement. Symptoms can include lack of balance, loss of coordination and the ability to walk, spasms and spasticity. Many of those with ataxia also have fatigue, vision loss, and problems hearing, speaking and swallowing.

"Ataxia is less common than neuro-muscular and movement disorders such as Parkinson's Disease and Multiple Sclerosis," said meeting organizer Christopher Gomez, MD, PhD, professor and chair of neurology at the University of Chicago. "As a consequence, we know much less about ataxia," he added, "but that is changing rapidly. In the past twenty years there has been an explosion of genetic discovery that has revolutionized our understanding and approach to diagnosis of ataxia. Those insights should lead over time to better treatments."

This is one of the few scientific meetings focused entirely on ataxia and it brings together most of the leading investigators in this field. It's also a chance for well-informed patients who come to Chicago for the annual patient and family meeting to catch up on the latest research in this small but expanding specialty."

The NAF is a Minnesota-based not-for-profit organization that focuses on raising awareness and medical research funding for new treatments or a potential cure for of ataxia.

National Ataxia Foundation AIM 2010 - 3rd Ataxia Investigators' Meeting

TUESDAY MARCH 9, 2010

7 PM Opening Remarks Christopher M. Gomez
KEYNOTE ADDRESS Christian Hansel, University of Chicago, "Cerebellar Learning and Connectivity"

WEDNESDAY MARCH 10, 2010

8:00 AM Theme 1 Cerebellar Function (and episodic) Dysfunction
8:00 AM Episodic ataxias: an overview, Joanna C. Jen, UCLA
8:30 AM Episodic ataxias: physiological mechanisms, Ellen Hess, Emory University
9:00 AM The therapeutic mode of action of 4-AP in Episodic ataxia, K Khodakhah, Albert Einstein College of Medicine

Theme 2 Molecular pathogenesis of autosomal dominant ataxias
10:00 AM SCA2 and SCA13, Stefan M. Pulst, University of Utah
10:30 AM SCA3, Henry L. Paulson, University of Michigan
11:00 AM SCA6, Christopher M. Gomez, University of Chicago
1:15 PM Invited Junior Lecturer Paula Ladd, University of California, San Diego
1:40 PM Invited Junior Lecturer Mirella Dottori, University of Melbourne
2:05 PM SCA7, Albert R. LaSpada, UCSD
2:35 PM SCA17, Xiao-Jiang Li, Emory University
3:30 PM SCA5 and SCA8, Laura PW Ranum, University of Minnesota
4:00 PM SCA10, Tee Ashizawa, University of Florida, Gainesville
4:30 PM Molecular pathophysiology of SCA14 caused by gamma PKC mutations, Norio Sakai, Hiroshima University, Hiroshima, Japan
5:00 PM Perspectives on dominant ataxia: insights from SCA1 that apply to other spinocerebellar ataxias, Harry T. Orr, University of Minnesota
5:30 PM KEYNOTE ADDRESS Richard Morimoto, Northwestern University, "The Proteostasis Challenge: The Stress of Misfolded Proteins in Aging and Disease"

THURSDAY MARCH 11, 2010

Theme 3 Molecular pathogenesis of recessively inherited ataxias
8:00 AM KEYNOTE ADDRESS Keith Caldecott University of Sussex, "Defects in DNA Single-Strand Break Repair and 8:45 AM The function of ATM in the central nervous system: beyond DNA breaks, Karl Herrup, Rutgers University
9:15 AM Senataxin, defective in AOA2, protects against oxidative stress and transcription dysregulation, Martin F. Lavin, Queensland Institute of Medical Research, Brisbane
9:45 AM Novel Recessive ataxias, Michel Koenig, Institut de Gntique, CNRS, Universit Louis-Pasteur
10:45 AM Overview of Friedreich's ataxia, Robert B. Wilson, University of Pennsylvania
11:15 AM Role of frataxin in iron-sulfur cluster biosynthesis, Grazia Isaya, Mayo Clinic Rochester
11:45 Frataxin gene regulation and pathways affected by frataxin deficiency, Massimo Pandolfo, Brussels

Theme 4 Moving towards therapy: Novel strategies and outcomes measures in ataxia
1:45 PM Friedreich's ataxia: Mitochondrial therapeutics, Sidney M. Hecht, Biodesign Institute, ASU
2:15 PM Invited Junior Lecturer - Alain Martelli, Institut de Genetique et de Biologie Moleculaire
2:40 PM Invited Junior Lecturer - Isabelle Iltis, University of Minnesota
3:05 PM Friedreich ataxia-5 Transcriptional enhancement with HDAC inhibitors, Joel M Gottesfeld, Scripps Institute, San Diego
4:00 PM Natural history studies and EuroSCA research network: 2010, Thomas Klockgether
4:30 PM Imaging correlates of SCA1 pathogenesis: From Biomarkers to Bioexplanations, Ana Solodkin, University of Chicago
5:00 PM MRS biomarkers for ataxias, Gulin Oz, CMRR, University of Minnesota.
5:30 PM Towards therapy for ataxia: how do we get there? Kurt Fischbeck, NINDS
6:00 PM Young Investigator Awards
7:00 PM KEYNOTE ADDRESS, Ole Isacson. Harvard University, "Stem cells and iPS cells: Paradigm shifts in cell therapeutics and discovery for neurodegenerative diseases


'/>"/>

Contact: John Easton
john.easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
Source:Eurekalert

Related biology news :

1. Charles Drew University, UC Irvine awarded $480,000 grant for research low birth weight infants
2. New University of Colorado paper shows novel way to study human inflammatory disease
3. University of Colorado study shows natural antioxidants give top barn swallows a leg on competitors
4. Stacking traits in algae is focus of grant to Iowa State University researcher
5. University of Minnesota scientist finds that big plant seeds dont always beat out small seeds
6. University of Oklahoma study reveals red hot results
7. Research at Marshall University may lead to new ways to transport and manipulate molecules
8. Boston University School of Medicine researcher awarded the 2010 Avanti Award in Lipids
9. Case Western Reserve University works with Johnson & Johnson Services Inc. on research grant
10. University of the Basque Country researchers decode transcriptome for gray mullet
11. Oxford University Press enters publishing partnership with Infectious Diseases Society of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2016)... PUNE, India , January 21, 2016 /PRNewswire/ ... According to a new market research report "Emotion ... Learning, and Others), Software Tools (Facial Expression, Voice ... and Regions - Global forecast to 2020", published ... Market is expected to reach USD 22.65 Billion ...
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... JOSE, Calif. , Jan. 11, 2016 ... of human interface solutions, today announced that its ClearPad ... driver integration (TDDI) products won two separate categories in ... Best Mobile Innovator and Best Technology Breakthrough. The Synaptics ... system cost, a simplified supply chain, thinner devices, brighter ...
Breaking Biology News(10 mins):
(Date:2/3/2016)... WARRINGTON, Pa. , Feb. 3, 2016 /PRNewswire/ ... biotechnology company focused on developing aerosolized KL4 surfactant ... Board of Directors has approved an inducement award ... Craig Fraser , its newly appointed President and ... the Board,s Compensation Committee on February 1, 2016 ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered organ ... and bronchus, today announced that CEO Jim ... CEO & Investor Conference on Tuesday, February ... New York City . HART,s presentation ...
(Date:2/3/2016)... ... February 03, 2016 , ... ProMIS Neurosciences is currently in ... to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company ... , Following on from the first misfolded Amyloid beta target announced on Nov. ...
(Date:2/3/2016)... 2016  Silk Therapeutics, Inc., today announced the closing of ... now raised a total of $10.25 million in Series A ... Series A2 round was led by existing investor The Kraft ... from new investors Lear Corporation and Highland Consumer Partners, as ... ; Richard Sackler , MD, with Summer Road, LLC; ...
Breaking Biology Technology: